Literature DB >> 22865229

Deacetylation of C/EBPβ is required for IL-4-induced arginase-1 expression in murine macrophages.

Neus Serrat1, Selma Pereira-Lopes, Mònica Comalada, Jorge Lloberas, Antonio Celada.   

Abstract

The amount of arginine available at inflammatory loci is a limiting factor for the growth of several cells of the immune system. IL-4-induced activation of macrophages produced arginase-1, which converts arginine into ornithine, a precursor of polyamines and proline. Trichostatin A (TSA), a pan-inhibitor of histone deacetylases (HDACs), inhibited IL-4-induced arginase-1 expression. TSA showed promoter-specific effects on the IL-4-responsive genes. While TSA inhibited the expression of arginase-1, fizz1, and mrc1, other genes, such as ym,1 mgl1, and mgl2, were not affected. The inhibition of arginase-1 occurred at the transcriptional level with the inhibition of polymerase II binding to the promoter. IL-4 induced STAT6 phosphorylation and binding to DNA. These activities were not affected by TSA treatment. However, TSA inhibited C/EBPβ DNA binding. This inhibitor induced acetylation on lysine residues 215-216, which are critical for DNA binding. Finally, using macrophages from STAT6 KO mice we showed that STAT6 is required for the DNA binding of C/EBPβ. These results demonstrate that the acetylation/deacetylation balance strongly influences the expression of arginase-1, a gene of alternative activation of macrophages. These findings also provide a molecular mechanism to explain the control of gene expression through deacetylase activity.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865229     DOI: 10.1002/eji.201242413

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway.

Authors:  Alia Shatanawi; Tahira Lemtalsi; Lin Yao; Chintan Patel; Ruth B Caldwell; R William Caldwell
Journal:  Eur J Pharmacol       Date:  2014-10-30       Impact factor: 4.432

2.  Shaping the murine macrophage phenotype: IL-4 and cyclic AMP synergistically activate the arginase I promoter.

Authors:  Kathryn E Sheldon; Harish Shandilya; Diane Kepka-Lenhart; Mirjana Poljakovic; Arundhati Ghosh; Sidney M Morris
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

3.  TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection.

Authors:  Ulrike Schleicher; Katrin Paduch; Andrea Debus; Stephanie Obermeyer; Till König; Jessica C Kling; Eliana Ribechini; Diana Dudziak; Dimitrios Mougiakakos; Peter J Murray; Renato Ostuni; Heinrich Körner; Christian Bogdan
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

Review 4.  Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages.

Authors:  Meera Rath; Ingrid Müller; Pascale Kropf; Ellen I Closs; Markus Munder
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

5.  Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24.

Authors:  Tao Yu; Shucheng Gan; Qingchen Zhu; Dongfang Dai; Ni Li; Hui Wang; Xiaosong Chen; Dan Hou; Yan Wang; Qiang Pan; Jing Xu; Xingli Zhang; Junli Liu; Siyu Pei; Chao Peng; Ping Wu; Simona Romano; Chaoming Mao; Mingzhu Huang; Xiaodong Zhu; Kunwei Shen; Jun Qin; Yichuan Xiao
Journal:  Nat Commun       Date:  2019-09-25       Impact factor: 14.919

Review 6.  Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections.

Authors:  Thierry Gauthier; Wanjun Chen
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

Review 7.  Epigenetic Control of Macrophage Polarisation and Soluble Mediator Gene Expression during Inflammation.

Authors:  Theodore S Kapellos; Asif J Iqbal
Journal:  Mediators Inflamm       Date:  2016-04-10       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.